True North Advisors LLC Makes New Investment in HCA Healthcare, Inc. (NYSE:HCA)

True North Advisors LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 1,243 shares of the company’s stock, valued at approximately $373,000.

Other hedge funds have also bought and sold shares of the company. Terra Nova Asset Management LLC boosted its stake in HCA Healthcare by 0.3% in the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after purchasing an additional 26 shares during the period. Massmutual Trust Co. FSB ADV grew its position in shares of HCA Healthcare by 7.4% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after purchasing an additional 29 shares in the last quarter. Waldron Private Wealth LLC grew its position in HCA Healthcare by 1.8% during the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock worth $683,000 after buying an additional 29 shares in the last quarter. Brookstone Capital Management boosted its position in shares of HCA Healthcare by 0.7% during the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after acquiring an additional 30 shares during the last quarter. Finally, UMB Bank n.a. raised its stake in HCA Healthcare by 2.4% in the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after purchasing an additional 30 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on HCA. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their price objective for the company from $400.00 to $320.00 in a research note on Monday, November 25th. Morgan Stanley cut their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. Cantor Fitzgerald restated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a report on Tuesday, October 1st. Finally, Truist Financial dropped their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. One research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $385.27.

HCA Healthcare Stock Up 0.3 %

NYSE:HCA opened at $319.53 on Thursday. HCA Healthcare, Inc. has a 1-year low of $278.68 and a 1-year high of $417.14. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The firm’s 50-day moving average price is $315.10 and its 200-day moving average price is $353.07. The company has a market capitalization of $80.94 billion, a PE ratio of 14.35, a P/E/G ratio of 1.08 and a beta of 1.64.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were issued a $0.66 dividend. The ex-dividend date of this dividend was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.83%. HCA Healthcare’s payout ratio is currently 11.85%.

Insiders Place Their Bets

In other news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. The trade was a 6.89 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.